{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:15:48Z","timestamp":1761894948849},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.mehy.2009.07.029","type":"journal-article","created":{"date-parts":[[2009,8,9]],"date-time":"2009-08-09T04:20:32Z","timestamp":1249791632000},"page":"118-119","source":"Crossref","is-referenced-by-count":8,"title":["A potential role for crystallization inhibitors in treatment of Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"74","author":[{"given":"F\u00e8lix","family":"Grases","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ant\u00f2nia","family":"Costa-Bauz\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael M.","family":"Prieto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2009.07.029_bib1","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0165-6147(91)90609-V","article-title":"Amyloid deposition as the central event in the aetiology of Alzheimer\u2019s disease","volume":"12","author":"Hardy","year":"1991","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.mehy.2009.07.029_bib2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0166-2236(00)02031-2","article-title":"Alzheimer\u2019s disease-do tauists and baptists finally shake hands?","volume":"25","author":"Mudher","year":"2002","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.mehy.2009.07.029_bib3","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.neurobiolaging.2006.06.023","article-title":"Alpha- and beta-secretase activity as a function of age and beta-amyloid in down syndrome and normal brain","volume":"28","author":"Nistor","year":"2007","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.mehy.2009.07.029_bib4","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.neurobiolaging.2004.08.005","article-title":"Alzheimer disease and down syndrome: factors in pathogenesis","volume":"26","author":"Lott","year":"2005","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.mehy.2009.07.029_bib5","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1056\/NEJM199511093331902","article-title":"Dementia, and cortical deposition of beta-amyloid protein","volume":"333","author":"Polvikoski","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mehy.2009.07.029_bib6","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1042\/BST20051041","article-title":"Utrecht diabetic encephalopathy study group. increased risk of Alzheimer\u2019s disease in Type II Diabetes: insulin resistance of the brain or insulin-induced amyloid pathology?","volume":"33","author":"Biessels","year":"2005","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.mehy.2009.07.029_bib7","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.bbadis.2008.12.003","article-title":"(Pre)diabetes, brain aging, and cognition","volume":"1792","author":"Roriz-Filho","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.mehy.2009.07.029_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1034\/j.1600-079X.2003.02112.x","article-title":"The chemistry of melatonin\u2019s interaction with reactive species","volume":"34","author":"Allegra","year":"2003","journal-title":"J Pineal Res"},{"key":"10.1016\/j.mehy.2009.07.029_bib9","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s007020050018","article-title":"An assessment of the antioxidant and the antiamyloidogenic properties of melatonin: implications for Alzheimer\u2019s disease","volume":"107","author":"Pappolla","year":"2000","journal-title":"J Neural Transm"},{"key":"10.1016\/j.mehy.2009.07.029_bib10","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S1054-3589(08)60981-3","article-title":"Antioxidant actions of melatonin","volume":"38","author":"Reiter","year":"1997","journal-title":"Adv Pharmacol"},{"key":"10.1016\/j.mehy.2009.07.029_bib11","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0197-4580(01)00226-3","article-title":"Effects of age and dietary antioxidants on cerebral electron transport chain activity","volume":"22","author":"Sharman","year":"2001","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.mehy.2009.07.029_bib12","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0197-4580(01)00277-9","article-title":"Pinealectomy: behavioral and neuropathological consequences in a chronic cerebral hypoperfusion model","volume":"23","author":"De Butte","year":"2002","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.mehy.2009.07.029_bib13","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.neurobiolaging.2005.12.004","article-title":"Pinealectomy causes hippocampal CA1 and CA3 cell loss: reversal by melatonin supplementation","volume":"28","author":"De Butte","year":"2007","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.mehy.2009.07.029_bib14","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1177\/0748730405277492","article-title":"Melatonin: characteristics, concerns, and prospects","volume":"20","author":"Arendt","year":"2005","journal-title":"J Biol Rhythms"},{"key":"10.1016\/j.mehy.2009.07.029_bib15","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1196\/annals.1356.025","article-title":"Clinical perspectives for the use of melatonin as a chronobiotic and cytoprotective agent","volume":"1057","author":"Cardinali","year":"2005","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.mehy.2009.07.029_bib16","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.psyneuen.2006.01.009","article-title":"Normative data on the daily profile of urinary 6-sulfatoxymelatonin in healthy subjects between the ages of 20 and 84","volume":"31","author":"Mahlberg","year":"2006","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.mehy.2009.07.029_bib17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1034\/j.1600-079X.2003.01897.x","article-title":"Alterations in the circadian rhythm of salivary melatonin begin during middle-age","volume":"34","author":"Zhou","year":"2003","journal-title":"J Pineal Res"},{"key":"10.1016\/j.mehy.2009.07.029_bib18","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1210\/jc.84.1.323","article-title":"Decreased melatonin levels in postmortem cerebrospinal fluid in relation to aging, Alzheimer\u2019s disease, and apolipoprotein E-epsilon4\/4 genotype","volume":"84","author":"Liu","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.mehy.2009.07.029_bib19","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0531-5565(02)00198-5","article-title":"Melatonin rhythmicity: effect of age and Alzheimer\u2019s disease","volume":"38","author":"Skene","year":"2003","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.mehy.2009.07.029_bib20","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/BF00310377","article-title":"Structural and ultrastructural characteristics of human pineal gland, and pineal parenchymal tumors","volume":"88","author":"Jouvet","year":"1994","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.mehy.2009.07.029_bib21","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1148\/radiology.142.3.7063680","article-title":"Age-related incidence of pineal calcification detected by computed tomography","volume":"142","author":"Zimmermann","year":"1981","journal-title":"Radiology"},{"key":"10.1016\/j.mehy.2009.07.029_bib22","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s003920170046","article-title":"Physiochemical principles of cardiovascular calcification","volume":"90","author":"Tomazic","year":"2001","journal-title":"Z Kardiol"},{"key":"10.1016\/j.mehy.2009.07.029_bib23","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1079\/BJN2001389","article-title":"Phytate levels in diverse rat tissues: influence of dietary phytate","volume":"86","author":"Grases","year":"2001","journal-title":"Br J Nutr"},{"key":"10.1016\/j.mehy.2009.07.029_bib24","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0955-2863(01)00178-4","article-title":"Variation of InsP4, InsP5 and InsP6 levels in tissues and biological fluids depending on dietary phytate","volume":"12","author":"Grases","year":"2001","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.mehy.2009.07.029_bib25","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.neurobiolaging.2006.10.003","article-title":"Pineal calcification in Alzheimer\u2019s disease: an in vivo study using computed tomography","volume":"29","author":"Mahlberg","year":"2008","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.mehy.2009.07.029_bib26","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1034\/j.1600-079x.2002.1o838.x","article-title":"The neuroprotective activities of melatonin against the Alzheimer beta-protein are not mediated by melatonin membrane receptors","volume":"32","author":"Pappolla","year":"2002","journal-title":"J Pineal Res"},{"key":"10.1016\/j.mehy.2009.07.029_bib27","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1210\/en.141.2.487","article-title":"Daily melatonin administration to middle-aged male rats suppresses body weight, intraabdominal adiposity, and plasma leptin and insulin independent of food intake and total body fat","volume":"141","author":"Wolden-Hanson","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.mehy.2009.07.029_bib28","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1046\/j.1365-2265.2001.01232.x","article-title":"Influence of melatonin administration on glucose tolerance and insulin sensitivity of postmenopausal women","volume":"54","author":"Cagnacci","year":"2001","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987709005210?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987709005210?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T17:26:07Z","timestamp":1545067567000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987709005210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0306987709005210"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2009.07.029","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}